Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Horton JD, San Miguel FL, Membreno F, et al. Budd–Chiari syndrome: illustrated review of current management. Liver Int. 2008;28:455–66.
2. Zhang C, Gu V, Zhu G, Luo T, Yan C, Wang Z. Hybrid treatment for Budd–Chiari syndrome—a case report by 11-year follow up. Ann Vasc Surg. 2017;38(e1–319):e6.
3. Valla DC. Primary Budd–Chiari syndrome. J Hepatol. 2009;50:195–203.
4. Bogin V, Marcos A, Shaw-Stiffel T. Budd–Chiari syndrome: in evolution. Eur J Gastroenterol Hepatol. 2005;17:33–5.
5. Limdi NA, McGwin G, Goldstein JA, et al. Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin. Clin Pharmacol Ther. 2008;83:312–21.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献